These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 32986377)

  • 1. Integrative Bioinformatics Analysis Reveals Potential Target Genes and TNFα Signaling Inhibition by Brazilin in Metastatic Breast Cancer Cells.
    Hermawan A; Putri H
    Asian Pac J Cancer Prev; 2020 Sep; 21(9):2751-2762. PubMed ID: 32986377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of hub genes to regulate breast cancer metastasis to brain by bioinformatics analyses.
    Tang D; Zhao X; Zhang L; Wang Z; Wang C
    J Cell Biochem; 2019 Jun; 120(6):9522-9531. PubMed ID: 30506958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative Bioinformatics Study of Tangeretin Potential Targets for Preventing Metastatic Breast Cancer.
    Hermawan A; Putri H; Hanif N; Ikawati M
    Evid Based Complement Alternat Med; 2021; 2021():2234554. PubMed ID: 34335799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the key pathways and genes involved in HER2-positive breast cancer with brain metastasis.
    Lu X; Gao C; Liu C; Zhuang J; Su P; Li H; Wang X; Sun C
    Pathol Res Pract; 2019 Aug; 215(8):152475. PubMed ID: 31178227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatic identification of chemoresistance-associated microRNAs in breast cancer based on microarray data.
    Wang YW; Zhang W; Ma R
    Oncol Rep; 2018 Mar; 39(3):1003-1010. PubMed ID: 29328395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of key genes and pathways in pelvic organ prolapse based on gene expression profiling by bioinformatics analysis.
    Zhou Q; Hong L; Wang J
    Arch Gynecol Obstet; 2018 May; 297(5):1323-1332. PubMed ID: 29546564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of aberrantly methylated differentially expressed genes in breast cancer by integrated bioinformatics analysis.
    Yi L; Luo P; Zhang J
    J Cell Biochem; 2019 Sep; 120(9):16229-16243. PubMed ID: 31081184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis.
    Li F; Guo P; Dong K; Guo P; Wang H; Lv X
    J Comput Biol; 2019 Nov; 26(11):1278-1295. PubMed ID: 31233342
    [No Abstract]   [Full Text] [Related]  

  • 9. Investigating the therapeutic potential and mechanism of curcumin in breast cancer based on RNA sequencing and bioinformatics analysis.
    Wang R; Li J; Zhao Y; Li Y; Yin L
    Breast Cancer; 2018 Mar; 25(2):206-212. PubMed ID: 29139094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delineating the underlying molecular mechanisms and key genes involved in metastasis of colorectal cancer via bioinformatics analysis.
    Qi C; Chen Y; Zhou Y; Huang X; Li G; Zeng J; Ruan Z; Xie X; Zhang J
    Oncol Rep; 2018 May; 39(5):2297-2305. PubMed ID: 29517105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDM2 is a Potential Target Gene of Glycyrrhizic Acid for Circumventing Breast Cancer Resistance to Tamoxifen: Integrative Bioinformatics Analysis.
    Azzahra SNA; Hanif N; Hermawan A
    Asian Pac J Cancer Prev; 2022 Jul; 23(7):2341-2350. PubMed ID: 35901340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell RNA sequencing reveals the communications between tumor microenvironment components and tumor metastasis in osteosarcoma.
    Li J; Bai Y; Zhang H; Chen T; Shang G
    Front Immunol; 2024; 15():1445555. PubMed ID: 39324133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatics Analysis Identifies the Estrogen Receptor 1 (ESR1) Gene and hsa-miR-26a-5p as Potential Prognostic Biomarkers in Patients with Intrahepatic Cholangiocarcinoma.
    Qin X; Song Y
    Med Sci Monit; 2020 May; 26():e921815. PubMed ID: 32435051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Key Genes and Prognostic Analysis in HER2+ Breast Cancer.
    Weng Y; Liang W; Ji Y; Li Z; Jia R; Liang Y; Ning P; Xu Y
    Technol Cancer Res Treat; 2021; 20():1533033820983298. PubMed ID: 33499770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive bioinformatics study reveals targets and molecular mechanism of hesperetin in overcoming breast cancer chemoresistance.
    Hermawan A; Putri H; Utomo RY
    Mol Divers; 2020 Nov; 24(4):933-947. PubMed ID: 31659695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of core genes and potential molecular mechanisms in breast cancer using bioinformatics analysis.
    Liu F; Wu Y; Mi Y; Gu L; Sang M; Geng C
    Pathol Res Pract; 2019 Jul; 215(7):152436. PubMed ID: 31076281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis.
    Fang E; Zhang X
    Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression and DNA methylation analyses suggest that immune process-related ADCY6 is a prognostic factor of luminal-like breast cancer.
    Li W; Sang M; Hao X; Jia L; Wang Y; Shan B
    J Cell Biochem; 2020 Jul; 121(7):3537-3546. PubMed ID: 31886586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.